Precision For Medicine
Precision for Medicine, Oncology and Rare Disease is proud to offer the first comprehensive, fully integrated clinical development solution. We are devoted exclusively to oncology and rare disease, and our teams are passionate about improving the lives of these patients. By combining the progressive science of biomarkers and analytics with our excellence in complex clinical trial execution, we help innovators to invest wisely, discover value sooner and optimize the returns from research.
Contact Precision for Medicine, Oncology and Rare Disease via their website
News archive
04/11/2020 Precision Medicine nominated for Best CRO by OBN Awards...more
22/04/2020 Precision for Medicine Partners with Karyopharm on New COVID-19 Trial...more
08/04/2020 Precision for Medicine Reports Launch of ICT01 EVICTION Trial ...more
27/01/2020 Precision For Medicine Appoints Executive Vice President, Clinical Solutions ...more
05/12/2019 Precision for Medicine, Oncology and Rare Disease Wins OBN Best Specialist CRO Award...more
27/11/2019 Precision for Medicine opens new 1,600 m2 Berlin-based laboratory...more
06/08/2019 Precision for Medicine Receives CIR (French Research Tax Credit) Accreditation...more
15/05/2019 Precision Medicine Group Will Be Attending ASCO 2019...more
06/03/2019 Precision for Medicine acquires SimplicityBio, AI engine to its QuartzBio™ platform...more
01/10/2018 Precision Medicine Group issues pre-ESMO POV..s.more
19/09/2018 Precision for Medicine, Oncology and Rare Disease Shortlisted for OBN Award...more
31/05/2018 Visit Precision Oncology at ASCO and BIO International Convention...more
12/07/2017 Precision Oncology joins the BioPartner programme...more
